Early studies show that a new mucosal vaccine against anthrax has the potential to provide military personnel with more effective and efficient protection against a “popular” bioweapon, according to a new study. With the new vaccine, researchers sought to take two steps at once, fine-tuning its ingredients and delivering it by nose spray instead of injection.